Adicet Bio, Inc. – LSE:0HX7.L

Adicet Bio stock price today

$16.997
+16.08
+1774.03%
Financial Health
0
1
2
3
4
5
6
7
8
9

Adicet Bio stock price monthly change

-25.04%
month

Adicet Bio stock price quarterly change

-25.04%
quarter

Adicet Bio stock price yearly change

-45.36%
year

Adicet Bio key metrics

Market Cap
79.40M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-2.95
Revenue
N/A
EBITDA
-122.15M
Income
-139.79M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Adicet Bio stock price history

Adicet Bio stock forecast

Adicet Bio financial statements

Adicet Bio, Inc. (LSE:0HX7.L): Profit margin
Jun 2023 0 -32.40M
Sep 2023 0 -49.88M
Dec 2023 0 -29.48M
Mar 2024 0 -28.01M
Adicet Bio, Inc. (LSE:0HX7.L): Analyst Estimates
Dec 2023 0 -29.48M
Mar 2024 0 -28.01M
Oct 2025 0 -26.09M
Dec 2025 0 -26.45M
  • Analysts Price target

  • Financials & Ratios estimates

Adicet Bio, Inc. (LSE:0HX7.L): Debt to assets
Jun 2023 277633000 38.57M 13.89%
Sep 2023 233257000 38.58M 16.54%
Dec 2023 207295000 37.12M 17.91%
Mar 2024 293095000 34.29M 11.7%
Adicet Bio, Inc. (LSE:0HX7.L): Cash Flow
Jun 2023 -24.89M -1.50M 226K
Sep 2023 -21.23M -906K -59K
Dec 2023 -23.48M -136K 76K
Mar 2024 -22.84M -239K 110.96M

Adicet Bio alternative data

Adicet Bio, Inc. (LSE:0HX7.L): Employee count
Aug 2023 132
Sep 2023 132
Oct 2023 132
Nov 2023 132
Dec 2023 132
Jan 2024 132
Feb 2024 132
Mar 2024 143
Apr 2024 143
May 2024 143
Jun 2024 143
Jul 2024 143

Adicet Bio other data

  • What's the price of Adicet Bio stock today?

    One share of Adicet Bio stock can currently be purchased for approximately $17.

  • When is Adicet Bio's next earnings date?

    Unfortunately, Adicet Bio's (0HX7.L) next earnings date is currently unknown.

  • Does Adicet Bio pay dividends?

    No, Adicet Bio does not pay dividends.

  • How much money does Adicet Bio make?

    Adicet Bio has a market capitalization of 79.40M.

  • What is Adicet Bio's stock symbol?

    Adicet Bio, Inc. is traded on the LSE under the ticker symbol "0HX7.L".

  • What is Adicet Bio's primary industry?

    Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.

  • How do i buy shares of Adicet Bio?

    Shares of Adicet Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Adicet Bio have?

    As Jul 2024, Adicet Bio employs 143 workers.

  • When Adicet Bio went public?

    Adicet Bio, Inc. is publicly traded company for more then 4 years since IPO on 8 Jan 2021.

  • What is Adicet Bio's official website?

    The official website for Adicet Bio is adicetbio.com.

  • Where are Adicet Bio's headquarters?

    Adicet Bio is headquartered at 200 Clarendon Street, Boston, MA.

  • How can i contact Adicet Bio?

    Adicet Bio's mailing address is 200 Clarendon Street, Boston, MA and company can be reached via phone at +65 05039095.

Adicet Bio company profile:

Adicet Bio, Inc.

adicetbio.com
Exchange:

LSE

Full time employees:

143

Industry:

Medical - Pharmaceuticals

Sector:

Healthcare

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

200 Clarendon Street
Boston, MA 02116

:
ISIN: US0070021086
CUSIP: 76133L103